マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
造影剤の世界市場規模は2022年で49億ドル、2031年に78億ドル、市場の平均年成長率は5.2%になると予測されています。
当レポートでは、造影剤の市場予測-2031年、各種セグメント別市場分析(タイプ別、東洋方法別、国地域別、等)、COVID-19の影響分析、市場シェア分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
ヨウ素化合物
硫酸バリウム系化合物
ガドリニウム系化合物
マイクロバブル/マイクロスフェア
※(市場規模US$)
経口
直腸
静脈内/動脈内
その他
※(市場規模US$)
CT/X線
超音波
MRI
その他
※(市場規模US$)
腫瘍学
循環器
神経学
その他
※(市場規模US$)
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
GE Healthcare
Bayer AG
Bracco Diagnostic, Inc.
Guerbet Group
Lantheus Medical Imaging, Inc.
nanoPET Pharma GmbH
Subhra Pharma Pvt. Ltd.
Spago Nanomedical AB
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Contrast Media Market Analysis and Forecast, 2022-2031
5.1. Pipeline Analysis
5.2. List of Types of Diagnostic Imaging Tests
5.3. COVID-19 Pandemic Impact on Industry
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Iodine-based Compounds
6.3.2. Barium Sulfate-based Compounds
6.3.3. Gadolinium-based Compounds
6.3.4. Microbubbles/Microspheres
6.4. Market Attractiveness, by Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Administration, 2017–2031
7.3.1. Oral
7.3.2. Rectal
7.3.3. Intravenous/Intrarterial
7.3.4. Others
7.3.5. 7.4 Market Attractiveness, by Administration
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Imaging Modality, 2017–2031
8.3.1. CT/X-Ray
8.3.2. Ultrasound
8.3.3. MRI
8.3.4. Others
8.4. Market Attractiveness, by Imaging Modality
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Oncology
9.3.2. Cardiology
9.3.3. Neurology
9.3.4. Others
9.4. 9.4 Market Attractiveness, by Application
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Iodine-based Compounds
11.2.2. Barium Sulfate-based Compounds
11.2.3. Gadolinium-based Compounds
11.2.4. Microbubbles/Microspheres
11.3. Market Attractiveness, by Type
11.4. Market Value Forecast, by Administration, 2017–2031
11.4.1. Oral
11.4.2. Rectal
11.4.3. Intravenous/Intrarterial
11.4.4. Others
11.5. Market Attractiveness, by Administration
11.6. Market Value Forecast, by Imaging Modality, 2017–2031
11.6.1. CT/X-Ray
11.6.2. Ultrasound
11.6.3. MRI
11.6.4. Others
11.7. Market Attractiveness, by Imaging Modality
11.8. Market Value Forecast, by Application, 2017–2031
11.8.1. Oncology
11.8.2. Cardiology
11.8.3. Neurology
11.8.4. Others
11.9. Market Attractiveness, by Application
11.10. Market Value Forecast, by Country, 2022–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Type
11.11.2. By Administration
11.11.3. By Imaging Modality
11.11.4. Application
11.11.5. By Country
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Iodine-based Compounds
12.2.2. Barium Sulfate-based Compounds
12.2.3. Gadolinium-based Compounds
12.2.4. Microbubbles/Microspheres
12.3. Market Attractiveness, by Type
12.4. Market Value Forecast, by Administration, 2017–2031
12.4.1. Oral
12.4.2. Rectal
12.4.3. Intravenous/Intrarterial
12.4.4. Others
12.5. Market Attractiveness, by Administration
12.6. Market Value Forecast, by Imaging Modality, 2017–2031
12.6.1. CT/X-Ray
12.6.2. Ultrasound
12.6.3. MRI
12.6.4. Others
12.7. Market Attractiveness, by Imaging Modality
12.8. Market Value Forecast, by Application, 2017–2031
12.8.1. Oncology
12.8.2. Cardiology
12.8.3. Neurology
12.8.4. Others
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by Country/Sub-region, 2022–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Type
12.11.2. By Administration
12.11.3. By Imaging Modality
12.11.4. By Application
12.11.5. By Country/Sub-region
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Iodine-based Compounds
13.2.2. Barium Sulfate-based Compounds
13.2.3. Gadolinium-based Compounds
13.2.4. Microbubbles/Microspheres
13.3. Market Attractiveness, by Type
13.4. Market Value Forecast, by Administration, 2017–2031
13.4.1. Oral
13.4.2. Rectal
13.4.3. Intravenous/Intrarterial
13.4.4. Others
13.5. Market Attractiveness, by Administration
13.6. Market Value Forecast, by Imaging Modality, 2017–2031
13.6.1. CT/X-Ray
13.6.2. Ultrasound
13.6.3. MRI
13.6.4. Others
13.7. Market Attractiveness, by Imaging Modality
13.8. Market Value Forecast, by Application, 2017–2031
13.8.1. Oncology
13.8.2. Cardiology
13.8.3. Neurology
13.8.4. Others
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Type
13.11.2. By Administration
13.11.3. By Imaging Modality
13.11.4. By Application
13.11.5. By Country/Sub-region
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Iodine-based Compounds
14.2.2. Barium Sulfate-based Compounds
14.2.3. Gadolinium-based Compounds
14.2.4. Microbubbles/Microspheres
14.3. Market Attractiveness, by Type
14.4. Market Value Forecast, by Administration, 2017–2031
14.4.1. Oral
14.4.2. Rectal
14.4.3. Intravenous/Intrarterial
14.4.4. Others
14.5. Market Attractiveness, by Administration
14.6. Market Value Forecast, by Imaging Modality, 2017–2031
14.6.1. CT/X-Ray
14.6.2. Ultrasound
14.6.3. MRI
14.6.4. Others
14.7. Market Attractiveness, by Imaging Modality
14.8. Market Value Forecast, by Application, 2017–2031
14.8.1. Oncology
14.8.2. Cardiology
14.8.3. Neurology
14.8.4. Others
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Type
14.11.2. By Administration
14.11.3. By Imaging Modality
14.11.4. By Application
14.11.5. By Country/Sub-region
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. Iodine-based Compounds
15.2.2. Barium Sulfate-based Compounds
15.2.3. Gadolinium-based Compounds
15.2.4. Microbubbles/Microspheres
15.3. Market Attractiveness, by Type
15.4. Market Value Forecast, by Administration, 2017–2031
15.4.1. Oral
15.4.2. Rectal
15.4.3. Intravenous/Intrarterial
15.4.4. Others
15.5. Market Attractiveness, by Administration
15.6. Market Value Forecast, by Imaging Modality, 2017–2031
15.6.1. CT/X-Ray
15.6.2. Ultrasound
15.6.3. MRI
15.6.4. Others
15.7. Market Attractiveness, by Imaging Modality
15.8. Market Value Forecast, by Application, 2017–2031
15.8.1. Oncology
15.8.2. Cardiology
15.8.3. Neurology
15.8.4. Others
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Type
15.11.2. By Administration
15.11.3. By Imaging Modality
15.11.4. By Application
15.11.5. By Country/Sub-region
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. GE Healthcare
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Bayer AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bracco Diagnostic, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Guerbet Group
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Lantheus Medical Imaging, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. nanoPET Pharma GmbH
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Subhra Pharma Pvt. Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Spago Nanomedical AB
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
Table 1: Global Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 2: Global Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 3: Global Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 4: Global Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 5: Global Contrast Media Market Value (US$ Mn) Forecast, by Country/Region, 2017–2031
Table 6: North America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 7: North America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 8: North America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 9: North America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: Europe Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Europe Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Europe Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 13: Europe Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 14: Europe Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 18: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 19: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 22: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 23: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 24: Latin America Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 27: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Administration, 2017–2031
Table 28: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Imaging Modality, 2017–2031
Table 29: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast, by Application, 2017–2031
Figure 1: Global Contrast Media Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Contrast Media Market Value Share, by Type, 2022
Figure 3: Contrast Media Market Value Share, by Administration, 2022
Figure 4: Contrast Media Market Value Share, by Imaging Modality, 2022
Figure 5: Contrast Media Market Value Share, by Application, 2022
Figure 6: Global Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 7: Global Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 8: Global Contrast Media Market Value Share Analysis, by Administration 2022 and 2031
Figure 9: Global Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 10: Global Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 11: Global Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 12: Global Contrast Media Market Value Share Analysis, by Application 2022 and 2031
Figure 13: Global Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 14: Global Contrast Media Market Value Share Analysis, by Country, 2022 and 2031
Figure 15: Global Contrast Media Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 17: North America Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 18: North America Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 19: North America Contrast Media Market Value Share Analysis, by Administration 2022 and 2031
Figure 20: North America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 21: North America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 22: North America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 23: North America Contrast Media Market Value Share Analysis, by Application 2022 and 2031
Figure 24: North America Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 25: Europe Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 26: Europe Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 27: Europe Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 28: Europe Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 29: Europe Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 30: Europe Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 31: Europe Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 32: Europe Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 33: Europe Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 34: Europe Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 35: Europe Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 36: Asia Pacific Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 37: Asia Pacific Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 38: Asia Pacific Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 39: Asia Pacific Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 40: Asia Pacific Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 41: Asia Pacific Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 42: Asia Pacific Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 43: Asia Pacific Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 44: Asia Pacific Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 45: Asia Pacific Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 46: Asia Pacific Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 47: Latin America Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 48: Latin America Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 49: Latin America Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 50: Latin America Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 51: Latin America Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 52: Latin America Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 53: Latin America Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 54: Latin America Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 55: Latin America Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 56: Latin America Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 57: Latin America Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 58: Middle East & Africa Contrast Media Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 59: Middle East & Africa Contrast Media Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 60: Middle East & Africa Contrast Media Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 61: Middle East & Africa Contrast Media Market Value Share Analysis, by Type 2022 and 2031
Figure 62: Middle East & Africa Contrast Media Market Attractiveness Analysis, Type, 2023–2031
Figure 63: Middle East & Africa Contrast Media Market Value Share Analysis, by Administration, 2022 and 2031
Figure 64: Middle East & Africa Contrast Media Market Attractiveness Analysis, Administration, 2023–2031
Figure 65: Middle East & Africa Contrast Media Market Value Share Analysis, by Imaging Modality 2022 and 2031
Figure 66: Middle East & Africa Contrast Media Market Attractiveness Analysis, Imaging Modality, 2023–2031
Figure 67: Middle East & Africa Contrast Media Market Value Share Analysis, by Application, 2022 and 2031
Figure 68: Middle East & Africa Contrast Media Market Attractiveness Analysis, Application, 2023–2031
Figure 69: Global Contrast Media Market Share Analysis, by Company, 2022